Approval · Notice of Compliance 4566 · 1996
NAPROSYN: Notice of Compliance 4566
Issued August 2, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4566
- Date
- August 2, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revisions
- Therapeutic class
- Anti-inflammatory agent with analgesic and antipyretic properties
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROSYN | Not yet assigned | — |